Ultragenyx Pharmaceutical (RARE) Non Operating Investment Income (2018 - 2025)
Ultragenyx Pharmaceutical's Non Operating Investment Income was $678,000 in Q3 2025, unchanged from $678,000 a year earlier.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Non Operating Investment Income (2018 - 2025) Analysis & Trends
On a trailing twelve-month basis, Ultragenyx Pharmaceutical's Non Operating Investment Income was -$1.04 million through Sep 30, 2025; for FY2024, it was -$1.12 million.
- In earlier years, Non Operating Investment Income was $397,000 in FY2023, -$19.3 million in FY2022, -$42.06 million in FY2021 and $170.4 million in FY2020.
- Quarterly Non Operating Investment Income has moved between -$31.05 million (Q2 2021) and $79.06 million (Q4 2020) over five years.
- Per Business Quant data, RARE's Non Operating Investment Income in the three quarters before Q3 2025 was -$9,000 (Q2 2025), -$157,000 (Q1 2025) and -$1.55 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Ultragenyx Pharmaceutical | 1.50 Bn | -302.56 Mn | 180.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 678,000.00 |
| Jun 30, 2025 | -9,000.00 |
| Mar 31, 2025 | -157,000.00 |
| Dec 31, 2024 | -1.55 Mn |
| Sep 30, 2024 | 678,000.00 |
| Jun 30, 2024 | -3.99 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Dec 31, 2023 | 1.89 Mn |
| Sep 30, 2023 | -1.42 Mn |
| Jun 30, 2023 | 261,000.00 |
| Mar 31, 2023 | -334,000.00 |
| Dec 31, 2022 | 1.84 Mn |
| Sep 30, 2022 | -1.63 Mn |
| Jun 30, 2022 | -10.18 Mn |
| Mar 31, 2022 | -9.33 Mn |
| Dec 31, 2021 | -16.10 Mn |
| Sep 30, 2021 | 25.70 Mn |
| Jun 30, 2021 | -31.05 Mn |
| Mar 31, 2021 | -20.62 Mn |
| Dec 31, 2020 | 79.06 Mn |
API Access
Ultragenyx Pharmaceutical Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();